Preimplantation Genetic Testing for Aneuploidy (PGT-A)
Preimplantation Genetic Testing for Monogenic Disorders (PGT-M)
Clinical Whole Exome Sequencing (cWES)
Search
Genalive is gearing up to showcase its latest breakthroughs and innovations at the upcoming MEGMA (Middle East Genetic and Metabolic Academy) conference, scheduled to take place from 9-11 Nov 2023 at the Sheraton Riyadh Hotel & Towers, KSA. Genalive's participation in this esteemed event holds immense significance for the geneticist community, with a specific focus on its impact within the Kingdom of Saudi Arabia (KSA) and MENA region. This participation promises to shed light on the latest scientific insights in the field of genetics in MENA region, making it a vital milestone in the localization of genetic technologies.
Genalive is contributing to the advancement of genetic diagnosis within KSA, ensuring that the nation remains at the forefront of genetic innovation and tailored healthcare solutions to meet the unique needs and demographics of the region.
MEGMA, is a renowned platform for professionals in the fields of genetics and metabolism. It has gained international recognition for fostering collaboration and knowledge sharing among researchers, clinicians, and industry experts. This year's conference, in particular, is expected to draw significant attention due to the Saudi Arabia 2030 vision toward content localization.
Genalive has been a trailblazer in genetic research and diagnostics, consistently pushing the boundaries of what is achievable in this rapidly evolving field. It has made significant advancements in areas such as NGS sequencing, reproductive genetics, cancer genetics, and personalized medicine. With our participation at MEGMA, we aim to highlight our cutting-edge technologies, research findings, and the potential impact of our services on both patients and medical practitioners.
Genalive's presence at MEGMA is anticipated to be a pivotal moment for the geneticist community, offering a unique opportunity to learn, network, and explore the latest advancements in the field of genetics. The potential impact of Genalive's services on patients and the medical field as a whole marks their presence at MEGMA as a significant milestone.
